While the return on R&D investment from biopharma companies has been a disappointment since 2010 -- with a notable exception ...

Three national leaders gathered Wednesday to discuss the impact of the Drug Enforcement Administration's historic move to ...

After experiencing a brief boost during the COVID-19 pandemic, the pharma industry’s reputation has begun to drop again in ...

The two sides have decided to work closely on timely resolution of market access issues, deepen people-to-people contacts, ...

Pharma’s pandemic-era halo is slipping. After tracking a surge in the industry’s reputation, PatientView found patient groups ...

BioNTech is a biotech company with a strong cash position and a commercial program generating cash-flow. Explore more details ...

AboutInozymePharma Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, ...

aTyr Pharma (LIFE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on the stock ...

The death of a Milwaukee high school football coach has drawn attention to national drug shortages, as his family speaks out about their inability to access life-saving treatment. Jeff Bolle, 60, died ...

In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (LIFE) on Thursday reported a loss of $15.5 million in its first quarter. The San Diego-based company said it had a loss of 23 cents per share. The ...